skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Contrast media induced fibrillation: comparison of Angovist 370 and Renografin 76: work in progress. [Dogs]

Conference · · Radiology; (United States)
OSTI ID:6659943

Angiovist 370, a new formulation of meglumine/sodium diatrizoate, is being marketed for coronary arteriography. Angiovist 370 contains no significant calcium chelator additives, but according to manufacturer specifications may have a pH as low as 6.0. The contact times required to produce ventricular fibrillation with Angiovist 370 and with Renografin 76 were compared using a canine right coronary arteriography model. The fibrillation contact time was 32.2% longer for the Angiovist 370 than for the Renografin 76. The lower pH therefore does not appear to increase the risk of contrast media induced fibrillation.

Research Organization:
Univ. of Rochester Medical Center, NY
OSTI ID:
6659943
Journal Information:
Radiology; (United States), Vol. 152:1; Conference: 69. scientific assembly and annual meeting of the Radiological Society of North America, Chicago, IL, USA, 13 Nov 1983
Country of Publication:
United States
Language:
English